// App-Quantinova.ai

1606 : An Expanded Anti-citrullinated Protein Antibody Profile Derived Using Unsupervised Machine Learning Predicts Treatment Responses to Biologic Therapies in Rheumatoid Arthritis

Researchers

Presenter

  • nozima Aripova

Principal Investigators

  • George Reed

  • Bryant England

  • William Robinson

  • Dimitrios Pappas

  • Joel Kremer

  • Geoffrey Thiele

  • Ted Mikuls

Medical Centers

  • University of Nebraska Medical Center, Omaha, NE

  • The Corrona Research Foundation and University of Massachusetts, Albany, NY

  • Stanford School of Medicine, Stanford, CA

  • CorEvitas LLC, Waltham, MA, USA

  • The Corrona Research Foundation, Delray Beach, FL

  • Division of Radiology, University of Nebraska Medical Center, Omaha, NE

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • anti-CCP antibodies

  • Nucleoside diphosphate kinase A

Drug/Treatment

  • Abatacept

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved